facebook-page-view
Advertisement

Novartis AG

Cipla acquires India trademark rights for anti-diabetic drug from Novartis

Healthcare

16 December, 2019

Cipla acquires India trademark rights for anti-diabetic drug from Novartis

Indian pharmaceutical major Cipla Ltd has acquired the brand name and trademark rights for Vysov and Vysov M (Vildagliptin and ......

Eris Lifesciences buys anti-diabetic drug from Novartis for India market

Healthcare

04 December, 2019

Eris Lifesciences buys anti-diabetic drug from Novartis for India market

Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......

Patanjali top bidder for Ruchi Soya; Aurobindo eyes Novartis' generics biz

General

07 May, 2018

Patanjali top bidder for Ruchi Soya; Aurobindo eyes Novartis' generics biz

Patanjali Ayurved Ltd, the fast-moving consumer goods firm run by yoga guru Baba Ramdev, has made a Rs 4,000-4,500-crore bid ......

Premium
Samara Capital acquires several brands from Novartis

Healthcare

05 October, 2017

Samara Capital acquires several brands from Novartis

Private equity firm Samara Capital Partners Pvt. Ltd has acquired several brands in the women’s health segment from global pharmaceutical ......